Heart Transplantation and Cancer Risk in a BRCA1 Breast Cancer Survivor
Cancer survivorship in BRCA1 carriers adds complexity to post-transplant management. Multidisciplinary, personalized care is essential for optimizing outcomes in such high-risk patients.
Authors
- Kevin J. Clerkin (ORCID: https://orcid.org/0000-0001-8351-9219)
- D. Bae (ORCID: https://orcid.org/0000-0002-4699-3736)
- J. Raikhelkar
- F. Z. Ab. Latif
- Edward C. Lin
- Kyung Taek Oh (ORCID: https://orcid.org/0000-0002-4379-7238)
- melana yuzefpolskaya (ORCID: https://orcid.org/0000-0003-4729-8943)
- Carolyn Hennecken (ORCID: https://orcid.org/0000-0001-8816-7937)
- D. Lotan
- Mariam El-Ashmawy (ORCID: https://orcid.org/0000-0002-2335-4827)
- P.C. Colombo (ORCID: https://orcid.org/0000-0003-4977-3285)
- Eleanor Keller
- Laura Noteware (ORCID: https://orcid.org/0000-0001-9554-8930)
- Afsana Rahman (ORCID: https://orcid.org/0000-0002-2294-8690)
- Nir Uriel (ORCID: https://orcid.org/0000-0003-2301-3587)
- Gabriel Sayer
- Sun Hi Lee
- Adil Yunis
Institutions
- Columbia University Irving Medical Center (US)
- Columbia University (US)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2026-01-21
- DOI
- https://doi.org/10.1016/j.jaccas.2025.106608
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00